MGRX (Mangoceuticals) EBITDA Margin % : -1,597.14% (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mangoceuticals EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Mangoceuticals's EBITDA for the three months ended in Dec. 2024 was $-1.68 Mil. Mangoceuticals's Revenue for the three months ended in Dec. 2024 was $0.11 Mil. Therefore, Mangoceuticals's EBITDA margin for the quarter that ended in Dec. 2024 was -1,597.14%.

Mangoceuticals EBITDA Margin % Historical Data

The historical data trend for Mangoceuticals's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangoceuticals EBITDA Margin % Chart

Mangoceuticals Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

EBITDA Margin %

-22,088.89

-1,256.91

-1,292.53

Mangoceuticals Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBITDA Margin %	Get a 7-Day Free Trial								-1,050.00	-1,103.27	-1,328.22	-1,321.80	-1,597.14

Competitive Comparison of Mangoceuticals's EBITDA Margin %

For the Health Information Services subindustry, Mangoceuticals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mangoceuticals's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mangoceuticals's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Mangoceuticals's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Mangoceuticals EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Mangoceuticals's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-7.962	/	0.616
	=	-1,292.53 %

Mangoceuticals's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-1.677	/	0.105
	=	-1,597.14 %

Mangoceuticals (NAS:MGRX) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Mangoceuticals EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Mangoceuticals's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangoceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mangoceuticals Inc (NAS:MGRX) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

15110 N. Dallas Parkway, Suite 600, Dallas, TX, USA, 75248

Website

https://www.mangoceuticals.com

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.

Executives

Alex P. Hamilton	director	26 LOOP ROAD, BEDFORD NY 10506
Amanda Elizabeth Hammer	officer: Chief Operating Officer	5128 GADSDEN AVENUE, KELLER TX 76244
Jacob D. Cohen	director, 10 percent owner, officer: CEO	2101 GLENDALE DRIVE, PLANO TX 75023
Tiger Cub Trust	10 percent owner	19 RYDDINGTON PL, DALLAS TX 75230
Kenny Myers	director	5101 ADDISON CIRCLE,, UNIT 401,, ADDISON TX 75001
Lorraine Pamela D'alessio	director	8200 WILSHIRE BLVD, BEVERLY HILLS, CALIFORNIA CA 90211
Eugene M Johnston	officer: CFO	PO BOX 669047, CHARLOTTE NC 28266
Jonathan Arango	director, officer: President, COO and Secretary	15110 DALLAS PARKWAY, SUITE 600, DALLAS TX 75248